Peptide Safely
Mostly animal studiesRecoveryBlend

BPC-157 + TB-500

Also called Wolverine stack, Wolverine blend, BPC/TB blend

Two popular healing peptides in one vial, nicknamed the Wolverine stack.

Get BPC-157 + TB-500 ↗Plan my suppliesTested by Vertex Labs. We may earn a commission.
Typical dose500–1,000 µg of blend (250–500 µg BPC-157 + 250–500 µg TB-500)
How oftenOnce a day
Half-lifeBPC-157: under 30 minutes (animal data). Thymosin beta-4: a few hours (limited data).
Vial sizes10 mg, 20 mg

The simple version

What it does
It's meant to help injuries heal, based on animal studies of each part.
How people take it
500–1,000 µg of blend as a shot under the skin, once a day.
Know this
There are no human trials, and in rats the combo did no better than either peptide alone.

What's inside

What it is

This is a premixed vial of BPC-157 and TB-500, usually 5 mg of each (10 mg total), nicknamed the Wolverine stack after the comic-book hero who heals fast. BPC-157 is a lab-made piece of a protein found in stomach juice, and TB-500 is a lab-made version (or short piece) of thymosin beta-4, a protein your body uses to repair tissue. Neither is an approved medicine.

How it works

In animal studies, BPC-157 seems to help new blood vessels grow and helps tendon cells grow and move, while thymosin beta-4 helps cells move into a wound, helps blood vessels grow and calms swelling. The idea is that one works more on blood supply and the other more on moving repair cells in, so together they might cover more ground. That's a theory, not something proven in people.

What people use it for

  • Tendon and ligament injuries
  • Pulled muscles
  • Injuries that heal slowly
  • Joint pain after training

The evidence

Mostly animal studies

Each part has animal and lab studies, but there are no good human trials of either one for injuries, and none of the blend. One 2026 rat study tested both on cut Achilles tendons: each helped alone, but the combo did no better than either one, so the idea that they add up isn't supported yet. Everything people say about this blend comes from personal experience, not trials.

How people dose it

Label doseFDA labelTrial doseclinical trialsReportedcommon use, untested

Standard

Reported
Dose
500–1,000 µg of blend (250–500 µg BPC-157 + 250–500 µg TB-500)
How often
Once a day
When
Any time. Some split it into a morning and a night shot.
Cycle
4–6 weeks, then a break of similar length
Route
Subcutaneous injection, often near the injured area

Why: You dose by the BPC-157 part, since its usual daily range is the best known. In a 1:1 vial, a daily BPC-157 dose also gives you about 1.75–3.5 mg of TB-500 a week. That's close to what people use when taking TB-500 alone. Example: add 2 mL of bacteriostatic water to a 10 mg vial. That makes 5 mg/mL of blend (2.5 mg/mL of each). A 500 µg dose is 0.1 mL, or 10 units on a U-100 insulin syringe, and gives 250 µg of each peptide.

Low/starter

Reported
Dose
250 µg of blend (125 µg BPC-157 + 125 µg TB-500)
How often
Once a day
When
Any time
Cycle
First 1–2 weeks, then move to the standard dose if you feel fine
Route
Subcutaneous injection

Why: Starting low lets you see how your body reacts before you take more. With the 2 mL mix above, this is 0.05 mL, or 5 units.

Start at the low end, and change one thing at a time. If you take medication or have a health condition, check with a doctor first.

Mix & measure

Set up for a 10 mg vial. Change any number to match yours. New to this? Read how to mix a vial and mg vs mL vs units first.

mg
mL
–

Plan your supplies

Pick your dose and how long you'll run it. We'll count what you need.

µg
–
We may earn a commission from these links. Counts include one syringe and two swabs per dose.

Stay safe

Side effects

  • Redness, itching or a small lump where you inject
  • Tiredness or feeling wiped out
  • Headache
  • Dizziness or light-headedness
  • Nausea
  • Side effects from both peptides can add up, and you can't tell which one caused a problem

Skip it if

  • Any cancer now or in the past (both parts help new blood vessels grow, which tumors can use)
  • Pregnant or breastfeeding
  • Under 18
  • Competing in drug-tested sports
  • Before surgery, unless you've told your surgeon

Interactions

  • No drug interactions have been studied in people
  • Tell your doctor if you take blood thinners, since its effects on blood vessels aren't well studied

Get help right away for swelling of the face or throat, trouble breathing, chest pain, or a spreading, hot, red injection site.

Storage & legal

Storage

Powder: fridge or freezer, out of the light. Mixed: fridge, use within about 4 weeks. Don't freeze once mixed.

Legal status

FDA: Not approved, alone or together. FDA has listed BPC-157 among bulk substances with safety concerns for compounding (2023).

Sport (WADA): Prohibited. BPC-157 is named under S0. Thymosin beta-4 and its pieces fall under S2.

Often paired with

Common questions

Is the blend better than taking each one separately?

Not proven. The only study of the pair (in rats) found no extra benefit from combining them. The upside is fewer shots. The downside is you can't change one dose without changing the other.

How do I work out my dose?

Pick your BPC-157 dose first, then double it to get the total blend dose for a 1:1 vial. The TB-500 dose comes along with it.

What if I only want more TB-500?

You can't with this vial. Raising the dose raises both. If you want different amounts, use two separate vials.

Sources

  1. Biçer O, et al. Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study. Jt Dis Relat Surg. 2026;37(3):822-837. PubMed 42542926
  2. Staresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976-83. PubMed 14554208
  3. Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-8. PubMed 10469335
  4. Goldstein AL, et al. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37-51. PubMed 22074294
  5. Mendias CL, et al. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. 2026;56(8):1921-1935. PubMed 41966639

Last checked 2026-10